Marc Brisson

Summary

Country: Canada

Publications

  1. doi request reprint Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study
    Marc Brisson
    SP POS, Centre de Recherche du CHU de Québec, Quebec, Canada
    Vaccine 31:3863-71. 2013
  2. doi request reprint Sociodemographic inequalities in sexual activity and cervical cancer screening: implications for the success of human papillomavirus vaccination
    Melanie Drolet
    Centre de recherche du CHU de Québec Hôpital Saint Sacrement, 1050 Chemin Sainte Foy, Quebec G1S 4L8, Canada
    Cancer Epidemiol Biomarkers Prev 22:641-52. 2013
  3. doi request reprint Economic evaluation of human papillomavirus vaccination in developed countries
    Marc Brisson
    Departement de Medecine sociale et preventive, Universite Laval, Quebec, Que, Canada
    Public Health Genomics 12:343-51. 2009
  4. doi request reprint Different population-level vaccination effectiveness for HPV types 16, 18, 6 and 11
    Marc Brisson
    Departement de Medecine sociale et preventive, Universite Laval, Quebec, Canada
    Sex Transm Infect 87:41-3. 2011
  5. ncbi request reprint Estimating the number needed to vaccinate to prevent herpes zoster-related disease, health care resource use and mortality
    Marc Brisson
    Départemente de médecine sociale et préventive, Universite Laval, Quebec, QC
    Can J Public Health 99:383-6. 2008
  6. ncbi request reprint The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia
    Marc Brisson
    Departement de Medecine sociale et preventive, Universite Laval, Quebec, Canada
    Hum Vaccin 4:238-45. 2008
  7. doi request reprint Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster
    Marc Brisson
    Departement de Medecine sociale et preventive, Universite Laval, Quebec, Canada
    Vaccine 28:3385-97. 2010
  8. doi request reprint Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity
    Marc Brisson
    Unité de recherche en santé des populations, Centre de recherche Fonds de la recherche en santé du Québec du Centre hospitalier affilié universitaire de Québec, Canada
    J Infect Dis 204:372-6. 2011
  9. pmc Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection
    Marc Brisson
    Departement de Medecine sociale et preventive, Universite Laval, Quebec, Que
    CMAJ 177:464-8. 2007
  10. ncbi request reprint The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada
    Marc Brisson
    Departement de Medecine sociale et preventive, Universite Laval, Que, Canada
    Vaccine 25:5399-408. 2007

Collaborators

Detail Information

Publications31

  1. doi request reprint Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study
    Marc Brisson
    SP POS, Centre de Recherche du CHU de Québec, Quebec, Canada
    Vaccine 31:3863-71. 2013
    ..The quadrivalent and bivalent human papillomavirus (HPV) vaccines are now licensed in several countries. We compared the cost-effectiveness of the HPV vaccines to provide evidence for policy decisions...
  2. doi request reprint Sociodemographic inequalities in sexual activity and cervical cancer screening: implications for the success of human papillomavirus vaccination
    Melanie Drolet
    Centre de recherche du CHU de Québec Hôpital Saint Sacrement, 1050 Chemin Sainte Foy, Quebec G1S 4L8, Canada
    Cancer Epidemiol Biomarkers Prev 22:641-52. 2013
    ..We aim to identify the sociodemographic characteristics of women who reported greater sexual activity and/or screening underuse...
  3. doi request reprint Economic evaluation of human papillomavirus vaccination in developed countries
    Marc Brisson
    Departement de Medecine sociale et preventive, Universite Laval, Quebec, Que, Canada
    Public Health Genomics 12:343-51. 2009
    ..The demand for modeling has resulted in the publication of numerous mathematical models looking at the cost-effectiveness of HPV vaccination...
  4. doi request reprint Different population-level vaccination effectiveness for HPV types 16, 18, 6 and 11
    Marc Brisson
    Departement de Medecine sociale et preventive, Universite Laval, Quebec, Canada
    Sex Transm Infect 87:41-3. 2011
    ..Given that the human papillomavirus (HPV) vaccine types have different durations of infectiousness and infectivity, the population-level vaccine effectiveness of these types may differ even if vaccine efficacy is identical...
  5. ncbi request reprint Estimating the number needed to vaccinate to prevent herpes zoster-related disease, health care resource use and mortality
    Marc Brisson
    Départemente de médecine sociale et préventive, Universite Laval, Quebec, QC
    Can J Public Health 99:383-6. 2008
    ..The aim of the study was to estimate the number needed to vaccinate (NNV) to prevent HZ-related outcomes...
  6. ncbi request reprint The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia
    Marc Brisson
    Departement de Medecine sociale et preventive, Universite Laval, Quebec, Canada
    Hum Vaccin 4:238-45. 2008
    ..In conclusion, results suggest that vaccinating adults between the ages of 65 and 75 years is likely to be cost-effective and thus to be a judicious use of scarce health care resources...
  7. doi request reprint Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster
    Marc Brisson
    Departement de Medecine sociale et preventive, Universite Laval, Quebec, Canada
    Vaccine 28:3385-97. 2010
    ..Adding a 2-dose program may help guarantee high population-level effectiveness against varicella. However, the incremental benefit of a second dose is highly dependant on the effectiveness of the first dose and its impact on zoster...
  8. doi request reprint Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity
    Marc Brisson
    Unité de recherche en santé des populations, Centre de recherche Fonds de la recherche en santé du Québec du Centre hospitalier affilié universitaire de Québec, Canada
    J Infect Dis 204:372-6. 2011
    ..Given the important predicted herd immunity impact of vaccinating girls under moderate to high vaccine coverage, the potential incremental gains of vaccinating boys are limited...
  9. pmc Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection
    Marc Brisson
    Departement de Medecine sociale et preventive, Universite Laval, Quebec, Que
    CMAJ 177:464-8. 2007
    ..A vaccine against human papillomavirus (HPV) types 6, 11, 16 and 18 is now licensed for use in Canada and many other countries. We sought to estimate the number needed to vaccinate to prevent HPV-related diseases and death...
  10. ncbi request reprint The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada
    Marc Brisson
    Departement de Medecine sociale et preventive, Universite Laval, Que, Canada
    Vaccine 25:5399-408. 2007
    ..Clinical trials have shown prophylactic human papillomavirus (HPV) vaccines to be effective against infection and disease. We examined whether HPV vaccination has the potential to be cost-effective...
  11. doi request reprint Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: a Canadian prospective study
    Marc Brisson
    Departement de Medecine sociale et preventive, Universite Laval, Quebec, QC, Canada
    Pediatr Infect Dis J 29:73-5. 2010
    ..Our results show that RGE impacts the health-related quality of life of children and parents adversely...
  12. doi request reprint Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis
    Nicolas Van de Velde
    Centre de Recherche FRSQ du CHA Universitaire de Québec, Quebec, Canada
    J Natl Cancer Inst 104:1712-23. 2012
    ..Furthermore, clinical trials examining the efficacy of a nonavalent vaccine are underway. We aimed to compare the potential population-level effectiveness of the bivalent, quadrivalent, and candidate nonavalent HPV vaccines...
  13. doi request reprint The psychosocial impact of an abnormal cervical smear result
    Melanie Drolet
    URESP, Centre de Recherche FRSQ du CHA Universitaire de Québec, Quebec City, Quebec, Canada
    Psychooncology 21:1071-81. 2012
    ....
  14. doi request reprint The impact of anogenital warts on health-related quality of life: a 6-month prospective study
    Melanie Drolet
    URESP, Centre de Recherche FRSQ du CHA Universitaire de Québec, Quebec, Quebec, Canada
    Sex Transm Dis 38:949-56. 2011
    ..We conducted a multicenter prospective study to (1) describe the impact of anogenital warts on quality of life and (2) estimate the quality-adjusted life-years (QALYs) lost due to anogenital warts...
  15. doi request reprint Association between prodromal pain and the severity of acute herpes zoster and utilization of health care resources
    Atika Benbernou
    Centre de Recherche FRSQ du CHA Universitaire de Québec, Quebec, Canada
    Eur J Pain 15:1100-6. 2011
    ..Herpes zoster results from the reactivation of the varicella-zoster virus, which is often accompanied by a prodrome of dermatomal pain. Little is known about the burden of prodromal pain...
  16. doi request reprint A prospective study of the herpes zoster severity of illness
    Melanie Drolet
    Centre Hospitalier Affilie Universitaire De Quebec, Hôpital Saint Sacrement, Quebec, QC, Canada
    Clin J Pain 26:656-66. 2010
    ....
  17. doi request reprint Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study
    Melanie Drolet
    URESP, Centre de Recherche FRSQ du CHA Universitaire de Québec, QC, Canada
    J Pain 11:1211-21. 2010
    ..These findings will contribute to optimal use of the HZ vaccine and testing of new therapies that might prevent PHN...
  18. doi request reprint Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective study
    Melanie Drolet
    URESP, Centre de Recherche FRSQ du CHA Universitaire de Québec, QC, Canada
    Vaccine 30:2047-50. 2012
    ..These results provide new information about the burden of HZ and PHN, which is useful for public health planning and cost-effectiveness analyses of HZ vaccination among individuals of working age...
  19. doi request reprint The impact of differential uptake of HPV vaccine by sexual risks on health inequalities: a model-based analysis
    Talía Malagón
    Centre de Recherche du CHU de Québec, Quebec, Canada
    Vaccine 31:1740-7. 2013
    ..Our aim was to illustrate how differential HPV vaccine uptake by sexual behaviour can impact population-level vaccination effectiveness and inequalities in HPV prevalence...
  20. doi request reprint Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine
    Melanie Drolet
    Centre de Recherche du CHU de Québec, Axe Santé des populations et pratiques optimales en santé, Quebec, Canada, G1S 4L8 Département de médecine sociale et préventive, Universite Laval, Quebec, Canada, G1V 0A6
    Int J Cancer 134:2264-8. 2014
    ..However, because most cervical cancers are caused by HPV-16/18, it is unlikely that the nonavalent would be used if its efficacy against these types is lower than current HPV vaccines. ..
  21. ncbi request reprint Modeling human papillomavirus vaccine effectiveness: quantifying the impact of parameter uncertainty
    Nicolas Van de Velde
    Department of Social and Preventive Medicine, Laval University, Quebec, Canada
    Am J Epidemiol 165:762-75. 2007
    ..Important priorities for future research are to understand the role of natural immunity and to measure the duration of vaccine protection because results were most sensitive to these parameters...
  22. doi request reprint Loss of quality of life associated with genital warts: baseline analyses from a prospective study
    Martin Senecal
    Merck Frosst Canada Ltd, Montreal, Quebec, Canada
    Sex Transm Infect 87:209-15. 2011
    ..The findings are described in terms that are more specific to individuals with genital warts using psychosocial questions adapted from the HPV impact profile, a measure developed for HPV-related conditions...
  23. pmc The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study
    Melanie Drolet
    Unité de recherche en santé des populations, Centre Hospitalier Affilie Universitaire De Quebec, Quebec, Que
    CMAJ 182:1731-6. 2010
    ..Vaccination against herpes zoster is being considered in many countries. We conducted a multicentre prospective study to describe the impact of herpes zoster and postherpetic neuralgia on health-related quality of life...
  24. doi request reprint Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
    Talía Malagón
    Unité de Recherche en Santé des Populations URESP, Centre de Recherche Fonds de la Recherche en Santé du Québec FRSQ du Centre Hospitalier Affilié Universitaire de Québec CHA, Quebec, Canada
    Lancet Infect Dis 12:781-9. 2012
    ....
  25. doi request reprint Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis
    Nicolas Van de Velde
    Departement de Medecine sociale et preventive, Universite Laval, Quebec, QC, Canada
    Vaccine 28:5473-84. 2010
    ....
  26. ncbi request reprint An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia
    Heather McDonald
    Innovus Research Inc, Burlington, Ontario, Canada
    Can J Urol 11:2327-40. 2004
    ....
  27. ncbi request reprint A cost-utility analysis of losartan versus atenolol in the treatment of hypertension with left ventricular hypertrophy
    Aslam H Anis
    Department of Health Care and Epidemiology, University of British Columbia, Vancouver, British Columbia, Canada
    Pharmacoeconomics 24:387-400. 2006
    ..Incorporating the results found in the LIFE study into an economic model, an incremental cost-effectiveness analysis was performed comparing losartan with atenolol in the treatment of 67-year old patients with hypertension and LVH...
  28. ncbi request reprint Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults
    James M Pellissier
    Merck Research Laboratories, Blue Bell, PA, United States
    Vaccine 25:8326-37. 2007
    ..s.)...
  29. ncbi request reprint Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia
    Marc Brisson
    Clin Infect Dis 45:1527-9. 2007
  30. ncbi request reprint The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales
    W John Edmunds
    Immunisation Division, PHLS Communicable Disease Surveillance Centre, 61 Collindale Avenue, NW9 5EQ, London, UK
    Vaccine 20:1316-30. 2002
    ..Significant uncertainty remains regarding the epidemiology of pertussis and the impact of booster doses. Nevertheless, the introduction of acellular boosters, particularly at 4 years, has the potential to be cost-effective in the UK...